Sinonasal non-Hodgkin's lymphomas and Wegener's granulomatosis: a clinicopathological study

Virchows Arch A Pathol Anat Histopathol. 1991;418(3):235-40. doi: 10.1007/BF01606061.

Abstract

Reports of sinonasal non-Hodgkin's lymphomas, analysed with monoclonal antibodies, are scarce, and differentiation of these lymphomas from Wegener's granulomatosis can be difficult. In this study, we investigated histopathologically and immunohistologically 20 cases of non-Hodgkin's lymphoma, primary in the sinonasal region, and sinonasal biopsies from 11 patients with Wegener's granulomatosis. All T-cell lymphomas (n = 7) and plasmacytomas (n = 4) were stage I at clinical presentation, while all B-cell lymphomas (n = 9) presented at higher stages. T-cell lymphomas tended to be more frequent in the nasal cavity and paranasal sinuses; B-cell lymphomas more often presented in the nasopharynx. Remarkably, 1 B-cell lymphoma expressed MT1, and 1 T-cell lymphoma expressed L26 (CD 20). The follow-up of 2 patients with a clinical diagnosis of Wegener's granulomatosis was suggestive of non-Hodgkin's lymphoma. Retrospective immunohistochemical analysis revealed that the original histological diagnosis of non-specific inflammation had to be changed to T-cell lymphoma, pleomorphic small cell type. We conclude that a biopsy from the sinonasal region with a dense inflammatory infiltrate, consisting predominantly of T-lymphocytes, renders a diagnosis of Wegener's granulomatosis unlikely and is at least suspicious of T-cell lymphoma. Immunohistochemical analysis is warranted for this type of biopsy.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antibodies, Neoplasm / analysis
  • Cyclophosphamide / therapeutic use
  • Female
  • Follow-Up Studies
  • Granulomatosis with Polyangiitis / immunology
  • Granulomatosis with Polyangiitis / mortality
  • Granulomatosis with Polyangiitis / pathology*
  • Humans
  • Immunohistochemistry
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology*
  • Male
  • Nose Neoplasms / immunology
  • Nose Neoplasms / mortality
  • Nose Neoplasms / pathology*
  • Paranasal Sinus Neoplasms / immunology
  • Paranasal Sinus Neoplasms / mortality
  • Paranasal Sinus Neoplasms / pathology*
  • Prednisone / therapeutic use
  • Survival Analysis

Substances

  • Antibodies, Neoplasm
  • Cyclophosphamide
  • Prednisone